View in EDS HTML Full Text

Josh Bilenker, MD, Former Medical Officer for FDA and Partner at Aisling Capital, Named to NCCN Foundation Board

Saved in:
Bibliographic Details
Title: Josh Bilenker, MD, Former Medical Officer for FDA and Partner at Aisling Capital, Named to NCCN Foundation Board
Authors: National Comprehensive Cancer Network
Source: Business Wire (English). 08/09/2012.
Abstract: The NCCN Foundation, which through private philanthropy and grants advances the mission of the National Comprehensive Cancer Network® (NCCN®) to improve the quality and effectiveness of care for patients with cancer, welcomes Josh Bilenker, MD, Partner at Aisling Capital and former Medical Officer for the U.S. Food and Drug Administration (FDA), as the newest member of the Board of the NCCN Foundation. [ABSTRACT FROM PUBLISHER]
Database: Regional Business News
Full text is not displayed to guests.
FullText Text:
  Availability: 1
Header DbId: bwh
DbLabel: Regional Business News
An: bizwire.c43361727
AccessLevel: 6
PubType: News
PubTypeId: newspaperArticle
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Josh Bilenker, MD, Former Medical Officer for FDA and Partner at Aisling Capital, Named to NCCN Foundation Board
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AR" term="%22National+Comprehensive+Cancer+Network%22">National Comprehensive Cancer Network</searchLink>
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22Business+Wire+%28English%29%22">Business Wire (English)</searchLink>. 08/09/2012.
– Name: Abstract
  Label: Abstract
  Group: Ab
  Data: The NCCN Foundation, which through private philanthropy and grants advances the mission of the National Comprehensive Cancer Network® (NCCN®) to improve the quality and effectiveness of care for patients with cancer, welcomes Josh Bilenker, MD, Partner at Aisling Capital and former Medical Officer for the U.S. Food and Drug Administration (FDA), as the newest member of the Board of the NCCN Foundation. [ABSTRACT FROM PUBLISHER]
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=bwh&AN=bizwire.c43361727
RecordInfo BibRecord:
  BibEntity:
    Languages:
      – Code: eng
        Text: English
    Titles:
      – TitleFull: Josh Bilenker, MD, Former Medical Officer for FDA and Partner at Aisling Capital, Named to NCCN Foundation Board
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: National Comprehensive Cancer Network
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 09
              M: 08
              Text: 08/09/2012
              Type: published
              Y: 2012
          Titles:
            – TitleFull: Business Wire (English)
              Type: main
ResultId 1